General Information of Drug (ID: DMNSJFD)

Drug Name
INDORAMIN Drug Info
Synonyms
INDORAMIN; Indoramine; 26844-12-2; Indoramina; Wy-21901; Indoraminum [INN-Latin]; Indoramine [INN-French]; Indoramina [INN-Spanish]; UNII-0Z802HMY7H; Baratol; EINECS 248-041-5; BRN 0494035; WY 21901; 0Z802HMY7H; CHEMBL279516; C22H25N3O; Benzamide, N-(1-(2-(1H-indol-3-yl)ethyl)-4-piperidinyl)-; 3-(2-(4-Benzamidopiperid-1-yl)ethyl)indole; JXZZEXZZKAWDSP-UHFFFAOYSA-N; N-(1-(2-Indol-3-ylethyl)-4-piperidyl)benzamide; N-(1-(2-(1H-Indol-3-yl)ethyl)-4-piperidinyl)benzamide; Benzamide, N-(1-(2-indol-3-ylethyl)-4-piperidyl)-; Benzamide, N
Cross-matching ID
PubChem CID
33625
ChEBI ID
CHEMBL279516
CAS Number
CAS 26844-12-2
TTD Drug ID
D02LHR
INTEDE Drug ID
DR0876

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
T cell receptor signaling pathway 1.96 3.54e-2 93/104 (89.42%) MAPK13;LCP2;RASGRP1;...
Malaria -1.67 3.68e-2 44/50 (88%) SELE;TLR4;KLRB1;...
Arginine biosynthesis -1.67 3.94e-2 17/22 (77.27%) ASL;GLUD1;GOT2;...
Prion disease -1.69 3.21e-2 209/273 (76.56%) COX6A1;PPIF;CASP3;...
Parkinson disease -1.72 2.51e-2 176/249 (70.68%) COX7C;VDAC3;BCL2L1;...
Glycine, serine and threonine metabolism -1.76 1.82e-2 31/40 (77.5%) GLDC;SHMT1;AGXT;...
Linoleic acid metabolism -1.76 1.84e-2 21/29 (72.41%) CYP2E1;CYP1A2;PLA2G4C;...
RNA degradation -1.82 1.11e-2 53/79 (67.09%) CNOT7;EDC3;MPHOSPH6;...
Ribosome -1.82 1.15e-2 113/158 (71.52%) RPL14;RPS15;RPS4X;...
Oxidative phosphorylation -1.83 1.19e-2 93/133 (69.92%) NDUFA1;ATP6V1B1;TCIRG1;...
Porphyrin and chlorophyll metabolism -1.87 8.36e-3 23/43 (53.49%) BLVRB;CPOX;UGT2B4;...
Retinol metabolism -1.89 1.00e-2 41/68 (60.29%) UGT2B4;CYP1A1;CYP26B1;...
Proteasome -1.95 6.27e-3 44/46 (95.65%) PSMB4;PSMA4;PSMB8;...
Legionellosis -1.98 5.57e-3 51/57 (89.47%) C3;HSPA2;TLR4;...
Steroid hormone biosynthesis -1.98 8.36e-3 43/61 (70.49%) UGT2B4;CYP1A1;AKR1C2;...
Staphylococcus aureus infection -2.05 8.36e-3 72/95 (75.79%) HLA-DOB;KRT16;FPR1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 3.33uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.01uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.01uM - 2.22uM 24H